Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Simrat Randhawa"'
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/3e36965d1a2f48229d297f6577b9a06c
Autor:
Cristina Arriens, Y. K. Onno Teng, Ellen M. Ginzler, Samir V. Parikh, Anca D. Askanase, Amit Saxena, Keisha Gibson, Dawn J. Caster, Tatsuya Atsumi, Laura Lisk, Simrat Randhawa, Rashieda Gluck, Neil Solomons, Robert B. Huizinga
Publikováno v:
Arthritis Care & Research. WILEY
Arthritis Care & Research
Arthritis Care & Research
Objective: This integrated analysis evaluates the efficacy and safety of voclosporin, a novel calcineurin inhibitor, at 23.7 mg twice daily in combination with mycophenolate mofetil (MMF) and oral glucocorticoids in lupus nephritis (LN) using pooled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c2b117499236e83beda77190e71886
https://hdl.handle.net/1887/3566472
https://hdl.handle.net/1887/3566472
Autor:
Maria Dall’Era, Kenneth Kalunian, Michael Eaddy, Augustina Ogbonnaya, Eileen Farrelly, Eric Turowski, Vanessa Birardi, Neil Solomons, Simrat Randhawa, Paola Mina-Osorio
Publikováno v:
Journal of managed carespecialty pharmacy. 29(1)
Autor:
Dawn J. Caster, Ellen M. Ginzler, Laura Lisk, Robert B Huizinga, Brad H. Rovin, Cristina Arriens, Joshua Kaplan, Neil Solomons, Y K Onno Teng, Juanita Romero-Diaz, Keisha L. Gibson, Simrat Randhawa, Samir V. Parikh, Sandra V. Navarra
Publikováno v:
The Lancet, 397(10289), 2070-2080. ELSEVIER SCIENCE INC
Background Voclosporin, a novel calcineurin inhibitor approved for the treatment of adults with lupus nephritis, improved complete renal response rates in patients with lupus nephritis in a phase 2 trial. This study aimed to evaluate the efficacy and
Publikováno v:
Abstracts.
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Voclosporin is a novel calcineurin inhibitor with a favorable metabolic profile and a consistent dose-concentration relationship, potentially eliminating the need for therapeutic drug monitoring. We have previously reported the pr
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Voclosporin (VCS) is a novel high potency calcineurin inhibitor (CNI) with a favorable metabolic profile and a consistent predictable dose response potentially eliminating the need for therapeutic drug monitoring. The Aurinia Rena
Autor:
Nikolaos Sfikas, P. von Rosenstiel, Xiangyi Meng, Daniel Kantor, Simrat Randhawa, Robert A. Bermel, Ron Hashmonay
Publikováno v:
Multiple Sclerosis and Related Disorders. 4(3):273-280
Selective serotonin-reuptake inhibitors (SSRIs), commonly administered for depression and anxiety in patients with multiple sclerosis, are associated with QT interval prolongation. Fingolimod (FTY720; Gilenya(®), Novartis Pharma AG) is a first-in-cl
Autor:
Joshua A. Katz, Ashwini Kumar, Islam Shahin, Susette M. Coyle, Edward Lin, Simrat Randhawa, Stephen F. Lowry, Steve E. Calvano
Publikováno v:
Archives of Surgery. 133:1322
Background The responses of monocyte and neutrophil tumor necrosis factor receptor type 1 (TNFR-1) and TNFR-2 during systemic inflammation have been described previously. Several other members of the TNFR superfamily also appear to have regulatory ro